These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33173445)

  • 21. Yellow fever control: current epidemiology and vaccination strategies.
    Chen LH; Wilson ME
    Trop Dis Travel Med Vaccines; 2020; 6():1. PubMed ID: 31938550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-Emergence of Yellow Fever in Brazil during 2016-2019: Challenges, Lessons Learned, and Perspectives.
    de Oliveira Figueiredo P; Stoffella-Dutra AG; Barbosa Costa G; Silva de Oliveira J; Dourado Amaral C; Duarte Santos J; Soares Rocha KL; Araújo Júnior JP; Lacerda Nogueira M; Zazá Borges MA; Pereira Paglia A; Desiree LaBeaud A; Santos Abrahão J; Geessien Kroon E; Bretas de Oliveira D; Paiva Drumond B; de Souza Trindade G
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33143114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
    Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
    BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.
    Shearer FM; Longbottom J; Browne AJ; Pigott DM; Brady OJ; Kraemer MUG; Marinho F; Yactayo S; de Araújo VEM; da Nóbrega AA; Fullman N; Ray SE; Mosser JF; Stanaway JD; Lim SS; Reiner RC; Moyes CL; Hay SI; Golding N
    Lancet Glob Health; 2018 Mar; 6(3):e270-e278. PubMed ID: 29398634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The enigma of yellow fever in East Africa.
    Ellis BR; Barrett AD
    Rev Med Virol; 2008; 18(5):331-46. PubMed ID: 18615782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of Yellow fever virus outside the Amazon Basin, causing epidemics in Southeast Brazil, from 2016 to 2018.
    Rezende IM; Sacchetto L; Munhoz de Mello É; Alves PA; Iani FCM; Adelino TÉR; Duarte MM; Cury ALF; Bernardes AFL; Santos TA; Pereira LS; Dutra MRT; Ramalho DB; de Thoisy B; Kroon EG; Trindade GS; Drumond BP
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006538. PubMed ID: 29864115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow fever epizootics in non-human primates, Southeast and Northeast Brazil (2017 and 2018).
    Mares-Guia MAMM; Horta MA; Romano A; Rodrigues CDS; Mendonça MCL; Dos Santos CC; Torres MC; Araujo ESM; Fabri A; de Souza ER; Ribeiro ROR; Lucena FP; Junior LCA; da Cunha RV; Nogueira RMR; Sequeira PC; de Filippis AMB
    Parasit Vectors; 2020 Feb; 13(1):90. PubMed ID: 32075684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Risk and Elimination of Yellow Fever Epidemics.
    Ndeffo-Mbah ML; Pandey A
    J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective.
    Hansen CA; Staples JE; Barrett ADT
    Infect Drug Resist; 2023; 16():7141-7154. PubMed ID: 38023411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The global burden of yellow fever.
    Gaythorpe KA; Hamlet A; Jean K; Garkauskas Ramos D; Cibrelus L; Garske T; Ferguson N
    Elife; 2021 Mar; 10():. PubMed ID: 33722340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Does the Future Hold for Yellow Fever Virus? (II).
    Klitting R; Fischer C; Drexler JF; Gould EA; Roiz D; Paupy C; de Lamballerie X
    Genes (Basel); 2018 Aug; 9(9):. PubMed ID: 30134625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yellow fever in the diagnostics laboratory.
    Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C
    Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yellow fever: the recurring plague.
    Tomori O
    Crit Rev Clin Lab Sci; 2004; 41(4):391-427. PubMed ID: 15487593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neighbor danger: Yellow fever virus epizootics in urban and urban-rural transition areas of Minas Gerais state, during 2017-2018 yellow fever outbreaks in Brazil.
    Sacchetto L; Silva NIO; Rezende IM; Arruda MS; Costa TA; de Mello ÉM; Oliveira GFG; Alves PA; de Mendonça VE; Stumpp RGAV; Prado AIA; Paglia AP; Perini FA; Lacerda Nogueira M; Kroon EG; de Thoisy B; Trindade GS; Drumond BP
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008658. PubMed ID: 33017419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importation of yellow fever into China: assessing travel patterns.
    Wilder-Smith A; Leong WY
    J Travel Med; 2017 Jul; 24(4):. PubMed ID: 28426111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management and control of yellow fever virus: Brazilian outbreak January-April, 2018.
    Callender DM
    Glob Public Health; 2019 Mar; 14(3):445-455. PubMed ID: 30122143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological description of and response to a large yellow fever outbreak in Edo state Nigeria, September 2018 - January 2019.
    Nwachukwu William E; Oladejo J; Ofoegbunam CM; Anueyiagu C; Dogunro F; Etiki SO; Dachung BI; Obiekea C; Aderoju B; Akanbi K; Adeyemi IT; Famokun GA; Emelife O; Osamwonyi IW; Ochu CL; Abiode A; Ireye F; Chukwuji M; Ipadeola O; Saiki M; Okudo I; Nwodo D; Oteri JA; Ilori E; Mba N; Ihekweazu C
    BMC Public Health; 2022 Aug; 22(1):1644. PubMed ID: 36042438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yellow Fever Molecular Diagnosis Using Urine Specimens during Acute and Convalescent Phases of the Disease.
    de Rezende IM; Oliveira GFG; Costa TA; Khan A; Pereira LS; Santos TA; Alves PA; Calzavara-Silva CE; Martins-Filho OA; Teixeira-Carvalho A; LaBeaud AD; Drumond BP
    J Clin Microbiol; 2022 Aug; 60(8):e0025422. PubMed ID: 35916519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yellow fever risk assessment in the Central African Republic.
    Staples JE; Diallo M; Janusz KB; Manengu C; Lewis RF; Perea W; Yactayo S; Sall AA;
    Trans R Soc Trop Med Hyg; 2014 Oct; 108(10):608-15. PubMed ID: 24947520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.